Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Methods Mol Biol ; 2303: 595-603, 2022.
Article in English | MEDLINE | ID: mdl-34626409

ABSTRACT

Xylosides are small synthetic molecules consisting of a xylose molecule attached to an aglycone group and serve as primers in the assembly of core protein free glycosaminoglycans using cellular machinery. Synthetic xylosides hold great promise in many biomedical applications and as therapeutics. Recent advances in the study of xylosides have opened up the possibility of developing xylosides as therapeutics to achieve a desirable biological outcome through their selective priming and inhibitory activities toward glycosaminoglycan biosynthesis. The approach described, herein, will serve as a general strategy to comprehensively screen xylosides and evaluate their ability to promote or inhibit angiogenesis, a critical biological process that is dysregulated in over 70 human diseases.


Subject(s)
Glycosides/chemistry , Glycosaminoglycans , Humans , Neovascularization, Pathologic , Xylose
2.
Methods Mol Biol ; 2303: 779-788, 2022.
Article in English | MEDLINE | ID: mdl-34626422

ABSTRACT

The extracellular matrix (ECM) plays a pivotal role in the regulation of neural stem cell differentiation, axon guidance and growth, and neural plasticity. Glycosaminoglycans, such as heparan sulfate and chondroitin sulfate, are significant components of brain ECM that dictates neurogenesis and neural repair. Herein, we describe a simple method to assess the effect of xylsoides, which serve as primers and inhibitors of GAG biosynthesis, on human neural stem cell differentiation and neurite outgrowth in in vitro culture conditions.


Subject(s)
Stem Cell Niche , Cell Differentiation , Glycosides , Humans , Neuronal Outgrowth
3.
PLoS One ; 12(8): e0182301, 2017.
Article in English | MEDLINE | ID: mdl-28763512

ABSTRACT

Angiogenesis, the sprouting of new blood vessels from existing vasculature, involves multiple complex biological processes, and it is an essential step for hemostasis, tissue healing and regeneration. Angiogenesis stimulants can ameliorate human disease conditions including limb ischemia, chronic wounds, heart disease, and stroke. The current strategies to improve the bioavailability of pro-angiogenic growth factors, including VEGF and FGF2, have remained largely unsuccessful. This study demonstrates that small molecules, termed click-xylosides, can promote angiogenesis in the in vitro matrigel tube formation assay and the ex ovo chick chorioallantoic membrane assay, depending on their aglycone moieties. Xyloside treatment enhances network connectivity and cell survivability, thereby, maintaining the network structures on matrigel culture for an extended period of time. These effects were achieved via the secreted xyloside-primed glycosaminoglycans (GAG) chains that in part, act through an ERK1/2 mediated signaling pathway. Through the remodeling of GAGs in the extracellular matrix of endothelial cells, the glycan approach, involving xylosides, offers great potential to effectively promote therapeutic angiogenesis.


Subject(s)
Glycosides/chemistry , Neovascularization, Physiologic , Polysaccharides/chemistry , Angiogenesis Inducing Agents/therapeutic use , Animals , Cell Proliferation , Cell Survival , Chick Embryo , Chorioallantoic Membrane/chemistry , Female , Glycosaminoglycans/chemistry , Human Umbilical Vein Endothelial Cells , Humans , Regeneration
SELECTION OF CITATIONS
SEARCH DETAIL
...